[Clostridium difficile and diarrhea in infants in the first half-year of life]

Pediatriia
|January 1, 1992
PubMed

Insights

Clostridium difficile colonization begins early in infants, but this study found no direct link to infant diarrhea. Disruption of intestinal flora, not C. difficile, appears to be the primary cause.

Area of Science:

  • Microbiology
  • Pediatrics
  • Gastroenterology

Background:

  • Investigating the role of Clostridium in infant diarrhea is crucial for understanding pediatric gastrointestinal health.
  • Neonatal and infant gut colonization patterns by bacteria like Clostridium difficile are not fully characterized.
  • The potential etiological link between Clostridium species and diarrhea in early life requires further study.

Purpose of the Study:

  • To determine the etiological relationship between Clostridium and diarrhea in infants during the first six months of life.
  • To characterize the intestinal colonization patterns of Clostridium, including Clostridium difficile, in neonates and infants.

Main Methods:

  • Bacteriological fecal investigations were conducted on neonates and infants at various ages (1, 4, 14 days; 1, 3, 6 months).
  • Children's development and health status were monitored under home conditions throughout the study period.
  • Isolation and identification of Clostridium species, including C. difficile, and assessment of toxin activity were performed.

Main Results:

  • Intestinal colonization with Clostridium, including C. difficile, was observed as early as the 4th day of life in neonates.
  • Clostridium difficile was the most frequently isolated Clostridium type (29.1%), with colonization patterns showing variability.
  • No convincing evidence linked C. difficile to diarrhea; however, significant intestinal dysbiosis (imbalance) was noted, with reduced beneficial bacteria.

Conclusions:

  • While C. difficile colonization is common in early infancy, it was not found to be a direct cause of diarrhea in this cohort.
  • Disturbances in intestinal biocenosis, characterized by reduced bifidobacteria and lactobacilli, are likely responsible for infant diarrhea.
  • The high prevalence of C. difficile carriers suggests a potential risk for specific diarrheal diseases in hospital or antibiotic-treated settings.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...